Important information to consider when making flu vaccination decisions
What is your risk? Does being vaccinated decrease your risk?
Per the WA DOH, in Washington State flu season (2016/2017), there were 276 deaths associated with the flu.
Of those:
- 126 had gotten a flu vaccine
- 63 had not gotten a flu vaccine
- 88 unknown for vaccination status
- 266 people had pre-existing conditions
Information for the 2017/2018 season. :
Below Table 4 is from: DOH Washington State Influenza Update . DOH states: “Most deaths have occurred in people with underlying health conditions, or in people with no pre-existing conditions but who were elderly. One pediatric death has been reported.” We are inquiring DOH about vaccination status of fatality cases and will post when available.
Does being vaccinated for the flu prevent you from spreading influenza virus? No.
- A 2013 study published in the journal Clinical Infectious Diseases reported finding “no evidence that vaccination prevented household transmission once influenza was introduced.”
- The 2016 Cochrane Review concluded that “[o]ffering influenza vaccination to HCWs [healthcare workers] based in long term care homes may have little or no effect on the number of residents who develop laboratory-proven influenza compared with those living in care homes where no vaccination is offered.”
Why not?
- A study published in the Scandinavian Journal of Immunology in 2004 states: “The absence of immune response [to vaccination] in the nasal mucosa may indicate a lack of appropriate local influenza virus stimulation. An apparent drawback to traditional parenteral [i.e., intramuscular] vaccines is that they induce a weak and short-lived local mucosal immune response.” In other words, flu shots do not generate protective antibodies in the nasal mucosa, which harbors the flu virus upon infection along with the lower respiratory tract, where it causes more severe symptoms. So, even in case when the flu shot may protect you from the flu symptoms caused by vaccine-matching strains, you are still able to carry them in your nasal mucosa and spread them.
- You don’t have to rely upon the respiratory symptoms (sneezing and coughing) to spread the flu virus — aerosol shedding will suffice. And if you get the flu despite being vaccinated, you will be shedding the flu virus at increased rates, per this 2017 study published in PNAS. “We observed 6.3 (95% CI 1.9–21.5) times more aerosol shedding among cases with vaccination in the current and previous season compared with having no vaccination in those two seasons.”
Influenza Vaccine Causes Illness and Immune Dysfunction
“Conclusion: Immune suppression from the influenza vaccine has been observed in human studies, and is supported by findings of reduced CD8+ T cells in vaccinated humans. And these effects have been confirmed in multiple animal studies, using two different types of animals. It is clear that immune suppression from the influenza vaccine is a real effect.”
http://vaccinepapers.org/influenza-vaccine-immune-suppression/
Flu season hits Australia before the U.S., and can predict VE (Vaccine Effectiveness) here. The early numbers from Australia for the current 2017-2018 flu season was overall 33%, and ranged broadly depending on strain, and whether someone had gotten a flu vaccine the previous year (which dropped the effectiveness to 3%). For some strains in age 65+ groups the VE was in the negative numbers (meaning, it increased the risk of getting the flu). The full data can be found HERE.
Warning: Multi-dose flu vaccines contain 25mcg of mercury. Single-dose flu vaccines contain “trace amounts” which can be up to 1mcg of mercury. Workplace and other Flu Clinics often use the multi-dose vaccines.
An excellent explanation of why people get sick following flu vaccination can be found HERE.
And THIS new study, provides further insight into the immunological response to flu vaccination that increases your risk of other infections. ()
“We found no evidence of vaccine effectiveness in preventing within-household transmission once influenza was introduced.” PMCID: PMC3693492
Please see our Vaccination During Pregnancy Page.
Vaccines for preventing seasonal influenza and its complications in people aged 65 or older
“Authors’ conclusions:
“The available evidence is of poor quality and provides no guidance regarding the safety, efficacy or effectiveness of influenza vaccines for people aged 65 years or older. To resolve the uncertainty, an adequately powered publicly-funded randomised, placebo–controlled trial run over several seasons should be undertaken.
Vaccines for preventing influenza in healthy children
“Influenza vaccines are efficacious in preventing cases of influenza in children older than two years of age, but little evidence is available for children younger than two years of age. There was a difference between vaccine efficacy and effectiveness, partly due to differing datasets, settings and viral circulation patterns. No safety comparisons could be carried out, emphasising the need for standardisation of methods and presentation of vaccine safety data in future studies. In specific cases, influenza vaccines were associated with serious harms such as narcolepsy and febrile convulsions. It was surprising to find only one study of inactivated vaccine in children under two years, given current recommendations to vaccinate healthy children from six months of age in the USA, Canada, parts of Europe and Australia. If immunisation in children is to be recommended as a public health policy, large-scale studies assessing important outcomes, and directly comparing vaccine types are urgently required. The degree of scrutiny needed to identify all global cases of potential harms is beyond the resources of this review.”
http://www.cochrane.org/CD004879/ARI_vaccines-preventing-influenza-healthy-children
Influenza Vaccine Causes Illness and Immune Dysfunction
“Conclusion: Immune suppression from the influenza vaccine has been observed in human studies, and is supported by findings of reduced CD8+ T cells in vaccinated humans. And these effects have been confirmed in multiple animal studies, using two different types of animals. It is clear that immune suppression from the influenza vaccine is a real effect.”
Influenza Vaccine Causes Illness and Immune Dysfunction
Live Attenuated Influenza Vaccine Enhances Colonization of Streptococcus pneumoniae and Staphylococcus aureus in Mice
“While care should be taken to not overgeneralize the data described here to all vaccines, the broad implications suggest that live attenuated viral vaccines may have unintended consequences on important human bacterial pathogens unrelated to the vaccine target species. Furthermore, our findings suggest a role for laboratory models of multispecies interactions with vaccine strains to inform future vaccine monitoring and evaluation programs aimed at identifying thus far entirely unrealized “unconventional” effects, both beneficial and detrimental, of live attenuated viral vaccines and cross-species microbial dynamics.”
http://mbio.asm.org/content/5/1/e01040-13.full
Live Attenuated Influenza Virus Increases Pneumococcal Translocation and Persistence Within the Middle Ear
“Conclusions. While LAIV vaccination is safe and effective at reducing IAV and coinfection with influenza virus and bacteria, LAIV may increase bacterial transmigration to the middle ear and could thus increase the risk of clinically relevant acute otitis media. These data warrant further investigations into interactions between live attenuated viruses and naturally colonizing bacterial pathogens.
https://academic.oup.com/jid/article/212/2/195/890177/Live-Attenuated-Influenza-Virus-Increases
Impact of repeated vaccination on vaccine effectiveness against influenza A(H3N2) and B during 8 seasons.
“CONCLUSIONS: Current- and previous-season vaccination generated similar levels of protection, and vaccine-induced protection was greatest for individuals not vaccinated during the prior 5 years. Additional studies are needed to understand the long-term effects of annual vaccination.”
Repeated seasonal influenza vaccination among elderly in Europe: Effects on laboratory confirmed hospitalised influenza.
“Our results suggest that, regardless of patients’ recent vaccination history, current seasonal vaccine conferred some protection to vaccinated patients against hospitalisation with influenza A(H3N2) and B. Vaccination of patients already vaccinated in both the past two seasons did not seem to be effective against A(H1N1)pdm09. To better understand the effect of repeated vaccination, engaging in large cohort studies documenting exposures to vaccine and natural infection is needed.”
Influenza Vaccination of Healthcare Workers: Critical Analysis of the Evidence for Patient Benefit Underpinning Policies of Enforcement.
“CONCLUSIONS: The four cRCTs underpinning policies of enforced HCW influenza vaccination attribute implausibly large reductions in patient risk to HCW vaccination, casting serious doubts on their validity. The impression that unvaccinated HCWs place their patients at great influenza peril is exaggerated. Instead, the HCW-attributable risk and vaccine-preventable fraction both remain unknown and the NNV to achieve patient benefit still requires better understanding. Although current scientific data are inadequate to support the ethical implementation of enforced HCW influenza vaccination, they do not refute approaches to support voluntary vaccination or other more broadly protective practices, such as staying home or masking when acutely ill.
Increased risk of noninfluenza respiratory virus infections associated with receipt of inactivated influenza vaccine.
“Abstract: We randomized 115 children to trivalent inactivated influenza vaccine (TIV) or placebo. Over the following 9 months, TIV recipients had an increased risk of virologically-confirmed non-influenza infections (relative risk: 4.40; 95% confidence interval: 1.31-14.8). Being protected against influenza, TIV recipients may lack temporary non-specific immunity that protected against other respiratory viruses.”
Autoimmune/inflammatory syndrome induced by adjuvants (Shoenfeld’s syndrome) – An update
“In this review, we have summarized the updated literature on ASIA syndrome and the knowledge accumulated since 2013 in order to elucidate the association between the exposure to various adjuvant agents and its possible clinical manifestations.”
Reports detail risk of seizures in kids after flu vaccination
“The findings have not prompted any change in the federal recommendations for flu and pneumococcal vaccination in young children, but federal officials called for warnings to healthcare providers and parents, according to the discussion article. The Advisory Committee on Immunization Practices (ACIP) recommended the warnings after a subcommittee studied the data.”
The long-term effects of febrile seizures on the hippocampal neuronal plasticity – clinical and experimental evidence.
“Therefore, there is a small group of children in whom febrile seizures-induced hippocampal injury might occur. Identification of the target population for subsequent mesial temporal sclerosis is important for prevention and early intervention.”
FEBRILE SEIZURES by Ruth C. Shinnar, RN, MSN & Shlomo Shinnar, MD, PhD
“The one exception to the favorable prognosis is very prolonged febrile seizures lasting more than 30 minutes. These are also known as febrile status epilepticus. These very prolonged febrile seizures which occur in 5-9 % of children with febrile seizures can be associated with injury to the brain structure called the hippocampus and result in subsequent epilepsy. Approximately 30-40% of children with febrile status epilepticus will later develop epilepsy.”
The CDC recommends TdaP and Flu vaccination during pregnancy based on perceived safety, not actual studies showing safety for the fetus either in the short term or for long term health outcomes. The FDA has not licensed any vaccine for use during pregnancy for protection of the fetus. All data currently gathered comes not from clinical trials but from the use of these vaccines in pregnant women in the general population. Pregnant women are not being told. Namely, pregnant women are not told that they are in essence taking part in clinical trials. They are shoddily run clinical trials since reporting pregnancy outcomes following vaccination is not required. The true impact of vaccination during pregnancy is not known. Tdap vaccine, for instance, contains 250 mcg of aluminum, a known neurotoxin, which can cross the placental barrier.
Vaccines to prevent influenza in healthy adults
“The real impact of biases could not be determined for about 70% of the included studies (e.g. insufficient reporting details, very different scores among the items evaluated). About 20% of the included studies (mainly cohorts) had a high risk of bias. Just under 10% had good methodological quality.
“Influenza vaccines have a very modest effect in reducing influenza symptoms and working days lost in the general population, including pregnant women. No evidence of association between influenza vaccination and serious adverse events was found in the comparative studies considered in the review. This review includes 90 studies, 24 of which (26.7%) were funded totally or partially by industry. Out of the 48 RCTs, 17 were industry-funded (35.4%).”
http://www.cochrane.org/CD001269/ARI_vaccines-to-prevent-influenza-in-healthy-adults
More papers and articles:
Effectiveness of trivalent inactivated influenza vaccine in influenza-related hospitalization in children: a case-control study. https://www.ncbi.nlm.nih.gov/pubmed/22525386
Comparison of VAERS fetal-loss reports during three consecutive influenza seasons https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3888271/
Impact of influenza vaccination on seasonal mortality in the US elderly population. https://www.ncbi.nlm.nih.gov/pubmed/15710788
Reversion of Cold-adapted Live Attenuated Influenza Vaccine into a Pathogenic Virus. https://www.ncbi.nlm.nih.gov/pubmed/27440882
Increased Risk of Noninfluenza Respiratory Virus Infections Associated With Receipt of Inactivated Influenza Vaccine
https://academic.oup.com/cid/article/54/12/1778/455098
Association between the 2008-09 seasonal influenza vaccine and pandemic H1N1 illness during Spring-Summer 2009: four observational studies from Canada. https://www.ncbi.nlm.nih.gov/pubmed/20386731
Vaccination against human influenza A/H3N2 virus prevents the induction of heterosubtypic immunity against lethal infection with avian influenza A/H5N1 virus.
https://www.ncbi.nlm.nih.gov/pubmed/19440239
Influenza vaccine effectiveness in the community and the household.
https://www.ncbi.nlm.nih.gov/pubmed/23413420
Influenza Vaccination During Pregnancy: A Critical Assessment of the Recommendations of the Advisory Committee on Immunization Practices (ACIP)
http://www.jpands.org/vol11no2/ayoub.pdf
What, in Fact, Is the Evidence That Vaccinating Healthcare Workers against Seasonal Influenza Protects Their Patients? A Critical Review
https://www.hindawi.com/journals/ijfm/2012/205464/
Yearly influenza vaccinations: a double-edged sword?
https://www.ncbi.nlm.nih.gov/pubmed/19879807
Vaccines for preventing influenza in healthy adults
http://onlinelibrary.wiley.com/doi/10.1002/14651858.CD001269.pub5/abstract;jsessionid=258E8CBEC2880B8F27D1D4C77014CD3F.f02t04
Live Attenuated Influenza Vaccine Enhances Colonization of Streptococcus pneumoniae and Staphylococcus aureus in Mice
http://mbio.asm.org/content/5/1/e01040-13.full
Repeated influenza vaccination of healthy children and adults: borrow now, pay later?
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2870374/pdf/S0950268805005479a.pdf
Epidemiology of respiratory viral infections in children enrolled in a study of influenza vaccine effectiveness.
https://www.ncbi.nlm.nih.gov/pubmed/?term=24483149
Annual vaccination against influenza virus hampers development of virus-specific CD8⁺ T cell immunity in children.
https://www.ncbi.nlm.nih.gov/pubmed/?term=21880755
Vaccine Effectiveness Against Laboratory-confirmed Influenza in Healthy Young Children: A Case-Control Study.
https://www.ncbi.nlm.nih.gov/pubmed/?term=21079528
Infectious virus in exhaled breath of symptomatic seasonal influenza cases from a college community
http://www.pnas.org/content/early/2018/01/17/1716561115
***
Alternatives to influenza vaccination
Vitamin D
Please visit the Vitamin D Council website for great information, including links to studies. VITAMIN D COUNCIL.
Harvard Gazette Article: Study Confirms Vitamin D protects against colds and flu.
Natural compound coupled with specific gut microbes may prevent severe flu
“Now, a new study shows that a particular gut microbe can prevent severe flu infections in mice, likely by breaking down naturally occurring compounds — called flavonoids — commonly found in foods such as black tea, red wine and blueberries.”
Natural compound coupled with specific gut microbes may prevent severe flu
Vitamin A, infection, and immune function
“Vitamin A deficiency impairs innate immunity by impeding normal regeneration of mucosal barriers damaged by infection, and by diminishing the function of neutrophils, macrophages, and natural killer cells. Vitamin A is also required for adaptive immunity and plays a role in the development of T both-helper (Th) cells and B-cells. In particular, vitamin A deficiency diminishes antibody-mediated responses directed by Th2 cells, although some aspects of Th1-mediated immunity are also diminished.” https://www.ncbi.nlm.nih.gov/pubmed/11375434
Chinese medicinal herbs for influenza
“Most Chinese medical herbs in the included studies showed similar effects to antiviral drugs in preventing or treating influenza. Few were shown to be superior to antiviral drugs. No obvious adverse events were reported in the included studies. However, current evidence remains weak due to methodological limitations of the trials. More high-quality RCTs with larger numbers of participants and clear reporting are needed.” http://www.cochrane.org/CD004559/ARI_chinese-medicinal-herbs-for-influenza
Homeopathic Oscillococcinum® for preventing and treating influenza and influenza-like illness
“Authors’ conclusions:
“There is insufficient good evidence to enable robust conclusions to be made about Oscillococcinum® in the prevention or treatment of influenza and influenza-like illness. Our findings do not rule out the possibility that Oscillococcinum® could have a clinically useful treatment effect but, given the low quality of the eligible studies, the evidence is not compelling. There was no evidence of clinically important harms due to Oscillococcinum®. http://www.cochrane.org/CD001957/ARI_homeopathic-oscillococcinumr-for-preventing-and-treating-influenza-and-influenza-like-illness
Avoid suppressing the immune system
The effect on mortality of antipyretics in the treatment of influenza infection: systematic review and meta-analyis
“In conclusion, this systematic review and meta-analysis has shown an increased mortality rate in animals treated with antipyretics during infection with influenza A or B, with no informative randomized placebo-controlled trials in humans. We propose that randomized placebo-controlled trials of antipyretic use in pandemic and seasonal influenza in humans are urgently needed in order to establish appropriate evidence-based management guidelines.” https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2951171/
Randomized controlled trial of the effect of regular paracetamol on influenza infection
“Regular paracetamol had no effect on viral shedding, temperature or clinical symptoms in patients with PCR‐confirmed influenza. There remains an insufficient evidence base for paracetamol use in influenza infection.” https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4738455/
Elderberry Syrup
- Randomized study of the efficacy and safety of oral elderberry extract in the treatment of influenza A and B virus infections.
- The effect of Sambucol, a black elderberry-based, natural product, on the production of human cytokines: I. Inflammatory cytokines.
Vitamins
Vitamin c and Zinc studies
- The effectiveness of vitamin C in preventing and relieving the symptoms of virus-induced respiratory infections.“RESULTS: Overall, reported flu and cold symptoms in the test group decreased 85% compared with the control group after the administration of megadose Vitamin C.“CONCLUSION: Vitamin C in megadoses administered before or after the appearance of cold and flu symptoms relieved and prevented the symptoms in the test population compared with the control group.” https://www.ncbi.nlm.nih.gov/pubmed/10543583
- Vitamin C for preventing and treating the common cold“Regular supplementation trials have shown that vitamin C reduces the duration of colds, but this was not replicated in the few therapeutic trials that have been carried out. Nevertheless, given the consistent effect of vitamin C on the duration and severity of colds in the regular supplementation studies, and the low cost and safety, it may be worthwhile for common cold patients to test on an individual basis whether therapeutic vitamin C is beneficial for them. Further therapeutic RCTs are warranted.” http://onlinelibrary.wiley.com/doi/10.1002/14651858.CD000980.pub4/abstract
- Red ginseng and vitamin C increase immune cell activity and decrease lung inflammation induced by influenza A virus/H1N1 infection.
- A new mechanism of vitamin C effects on A/FM/1/47(H1N1) virus-induced pneumonia in restraint-stressed mice.
- In Silico Analysis to Compare the Effectiveness of Assorted Drugs Prescribed for Swine flu in Diverse Medicine Systems.
- Effect of oral gavage treatment with ZnAL42 and other metallo-ion formulations on influenza A H5N1 and H1N1 virus infections in mice.
- Low pH gel intranasal sprays inactivate influenza viruses in vitro and protect ferrets against influenza infection.
***
